Target : National, multicenter trial, evaluating the impact of abciximab versus placebo in patients with acute ST segment elevation myocardial infarction treated with primary angioplasty.
Trial date : 1999
Number of patients : 300
Source of funding : Private (Lilly)
Centers participating : 26 Centres Français
N°NCT: NCT00841438